Genomics England
Bojana Selinsek is a seasoned professional with extensive experience in product management, clinical trials, and international organizational leadership. Currently serving as a Senior Product Manager at Genomics England, Bojana leads the development of a multimodal cancer research platform aimed at enhancing cancer understanding and diagnosis. As President of Društvo VTIS, Bojana fosters connections among Slovenian experts globally. Previous roles include Product Manager at Kheiron Medical, Clinical Trials Manager at Cancer Research UK & UCL Cancer Trials Centre, and Clinical Trials Coordinator at the University of Oxford. Bojana holds multiple degrees in neuroscience, Slovenian language, linguistics, and media studies.
Genomics England
3 followers
Genomics England is a wholly owned company of the Department of Health set up to deliver the 100,000 Genomes Project. It was made possible by the National Institute for Health Research, NHS England, Public Health England, and Health Education England.Genomics England sequences 100,000 whole genomes from NHS patients and their families. Its fourmain aims include bringing benefit to patients, creating an ethical and transparent program based on consent, supporting new scientific discovery and medical insights, and kick-starting the development of the U.K. genomics industry.Genomics England is focusing on patients with rare diseases, and their families, as well as patients with common cancers. It was announced by Jeremy Hunt, Secretary of State for Health, as part of the NHS 65th birthday celebrations in 2013. It is based in London, England.